Galderma launches two new dermal fillers January 03, 2017By Bob KronemyerGalderma receives FDA approval for Restylane Refyne and Defyne, two next-generation HA fillers. Rapamycin may slow aging January 03, 2017By Bob KronemyerUsed as a transplant rejection inhibitor, therapy for renal cell carcinoma and as a stent coating, the rapamycin compound may also increase lifespan. Cost-effective correction of mid-face volume loss November 29, 2016By Lisette HiltonResearchers examine the practical application of a significantly lower dose of HA for midface volume correction compared with that used in pivotal trials. Toxin vs toxin: How do you choose? November 29, 2016By Randy DotingaBotox, Dysport and Xeomin may share similarities, but several factors can affect the best way to choose which is best for your individual patients. An authentic picture of the aging face November 29, 2016By Randy DotingaThink you know your way around the aging face? Think again. New research challenges assumptions about how the face changes over time. Measuring nonsurgical fat reduction November 01, 2016By Lisette HiltonResearchers offer a reproducible solution to quantify nonsurgical fat reduction results. ABCs and 123s of ona-, abo- and incobotulinumtoxinA November 01, 2016By Lisette HiltonA recently published stepwise approach to treating wrinkles provides a template for achieving safe, effective results with FDA-approved neurotoxins. No-touch lip enhancement November 01, 2016By Lisette HiltonAvoiding needle injection directly into the mucosa decreases swelling and bruising both during and after the procedure. Next-gen RF combo treatment October 04, 2016By Lisette HiltonA study using a combination bipolar RF+IR and fractionated RF protocol shows significant improvement in skin quality and delivers high marks in patient satisfaction. Laser treatment for permanent filler complications September 01, 2016By Bob KronemyerResearchers offer a novel approach and treatment algorithm for removing permanent fillers.